Ribavirin
Taéron, C.
Revue de l'Infirmiere 152: 47-49
2009
ISSN/ISBN: 1293-8505 PMID: 19702029 Document Number: 635708
Document emailed within 1 workday
Related Documents
Roberts, R.B.; Dickinson, G.M.; Heseltine, P.N.; Leedom, J.M.; Mansell, P.W.; Rodriguez, S.; Johnson, K.M.; Lubina, J.A.; Makuch, R.W. 1990: A multicenter clinical trial of oral ribavirin in HIV-infected patients with lymphadenopathy. the Ribavirin-LAS Collaborative Group Journal of Acquired Immune Deficiency Syndromes 3(9): 884-892Wong, J. B.; Nevens, F. 2002: Cost-effectiveness of peginterferon alfa-2b plus ribavirin compared to interferon alfa-2b plus ribavirin as initial treatment of chronic hepatitis C in Belgium Acta Gastro-Enterologica Belgica 65(2): 110-111
Cooper, K.E. 2001: The effectiveness of ribavirin in the treatment of RSV Pediatric Nursing 27(1): 95-98
Abramowicz, M. 2007: Peginterferon and ribavirin for hepatitis C New England Journal of Medicine 356(12): 1270-1271; Author Reply 1271
Mack, J.E. 1988: Ribavirin: an antiviral agent with promise Pediatric Nursing 14(3): 220-221
Durnev, A.D.; Daugel'-Dauge, N.O.; Seredenin, S.B. 2006: Comutagen interaction of verapamil and ribavirin Eksperimental'naia i Klinicheskaia Farmakologiia 69(1): 56-59
Sherman, C.R.; Fernandez, H. 1992: Scientific literature on ribavirin should be "objectively reviewed" Pediatric Nursing 18(6): 598
Kumta, N.B.; Antani, D.N. 1983: Ribavirin trial in cases of infective hepatitis Indian Pediatrics 20(2): 99-103
Carmack, M.A.; Prober, C.G. 1992: Respiratory syncytial virus and ribavirin: quo vadis? Infectious Agents and Disease 1(2): 99-107
Asnis, G.M.; De La Garza, R.; Miller, A.H.; Raison, C.L. 2004: Ribavirin may be an important factor in IFN-induced neuropsychiatric effects Journal of Clinical Psychiatry 65(4): 581; Author Reply 581-2
Tsilevich, T.L.; Shchaveleva, I.L.; Nosach, L.N.; Zhovnovataia, V.L.; Smirnov, I.P. 1988: Acyclic analogs of ribavirin. Synthesis and antiviral activity Bioorganicheskaia Khimiia 14(5): 689-693
Lagrota, M.H.; Ciribelli-Guimaräes, J.; Pereira, N.A.; Wigg, M.D.; Fonseca, M.E. 1982: Antiviral chemotherapy: in vitro activity of ribavirin on DNA and RNA viruses Revista Latinoamericana de Microbiologia 24(2): 121-124
Arase, Y. 2011: Combination therapy of PEG-interferon and ribavirin for chronic hepatitis C in Japan Nihon Rinsho. Japanese Journal of Clinical Medicine 69(Suppl 4): 191-195
Il'icheva, T.N.; Kulishova, L.A.; Shul'ts, E.E.; Petrenko, N.I.; Uzenkova, N.V.; Ias'ko, M.V.; Serova, O.A.; Volkov, G.N.; Belanov, E.F.; Tolstikov, G.A.; Pokrovskiĭ, A.G. 2005: Antiviral activity of vegetable triterpens, their derivatives and ribavirin phosphonates Vestnik Rossiiskoi Akademii Meditsinskikh Nauk 2005(2): 26-30
Margot, N.A.; Miller, M.D. 2005: In vitro combination studies of tenofovir and other nucleoside analogues with ribavirin against HIV-1 Antiviral Therapy 10(2): 343-348
Gunsar, F.; Akarca, U.S.; Ersoz, G.; Kobak, A.C.; Karasu, Z.; Yuce, G.; Ilter, T.; Batur, Y. 2005: Two-year interferon therapy with or without ribavirin in chronic delta hepatitis Antiviral Therapy 10(6): 721-726
Jensen, S.L.; Holmes, R. 2003: Rosacea fulminans associated with pegylated interferon alpha-2B and ribavirin therapy Journal of Drugs in Dermatology: Jdd 2(5): 554-556
Sánchez-Solís de Querol, M.; Castillo-Ochando, F.; Díaz-Torres, M.; Sayed-Sancho, N.; Sánchez-Flores, F.; Pajarón de Ahumada, M. 1997: Ribavirin in the treatment of bronchiolitis caused by syncytial respiratory virus Anales Espanoles de Pediatria 47(1): 14-16
Varghese, R.; Al-Khaldi, J.; Asker, H.; Fadili, A.A.; Al Ali, J.; Hassan, F.A. 2009: Treatment of chronic hepatitis C genotype 4 with peginterferon alpha-2a plus ribavirin Hepato-Gastroenterology 56(89): 218-222
Nunnari, G.; Montineri, A.; Portelli, V.; Savalli, F.; Fatuzzo, F.; Cacopardo, B. 2012: The use of peginterferon in monotherapy or in combination with ribavirin for the treatment of acute hepatitis C European Review for Medical and Pharmacological Sciences 16(8): 1013-1016